Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Pancreatology ; 14(1): 27-35, 2014.
Article in English | MEDLINE | ID: mdl-24555976

ABSTRACT

DESCRIPTION: Total pancreatectomy with islet autotransplantation (TPIAT) is a surgical procedure used to treat severe complications of chronic pancreatitis or very high risk of pancreatic cancer while reducing the risk of severe diabetes mellitus. However, clear guidance on indications, contraindications, evaluation, timing, and follow-up are lacking. METHODS: A working group reviewed the medical, psychological, and surgical options and supporting literature related to TPIAT for a consensus meeting during PancreasFest. RESULTS: Five major areas requiring clinical evaluation and management were addressed: These included: 1) indications for TPIAT; 2) contraindications for TPIAT; 3) optimal timing of the procedure; 4) need for a multi-disciplinary team and the roles of the members; 5) life-long management issues following TPIAP including diabetes monitoring and nutrition evaluation. CONCLUSIONS: TPIAT is an effective method of managing the disabling complications of chronic pancreatitis and risk of pancreatic cancer in very high risk patients. Careful evaluation and long-term management of candidate patients by qualified multidisciplinary teams is required. Multiple recommendations for further research were also identified.


Subject(s)
Islets of Langerhans Transplantation , Pancreatectomy , Pancreatitis, Chronic/surgery , Contraindications , Humans , Islets of Langerhans Transplantation/methods , Pancreatic Neoplasms/etiology , Pancreatic Neoplasms/surgery , Risk , Transplantation, Autologous
2.
Cancer Res ; 74(6): 1718-27, 2014 Mar 15.
Article in English | MEDLINE | ID: mdl-24448244

ABSTRACT

Perineural tumor invasion of intrapancreatic nerves, neurogenic inflammation, and tumor metastases along extrapancreatic nerves are key features of pancreatic malignancies. Animal studies show that chronic pancreatic inflammation produces hypertrophy and hypersensitivity of pancreatic afferents and that sensory fibers may themselves drive inflammation via neurogenic mechanisms. Although genetic mutations are required for cancer development, inflammation has been shown to be a precipitating event that can accelerate the transition of precancerous lesions to cancer. These observations led us to hypothesize that inflammation that accompanies early phases of pancreatic ductal adenocarcinoma (PDAC) would produce pathologic changes in pancreatic neurons and innervation. Using a lineage-labeled genetically engineered mouse model of PDAC, we found that pancreatic neurotrophic factor mRNA expression and sensory innervation increased dramatically when only pancreatic intraepithelial neoplasia were apparent. These changes correlated with pain-related decreases in exploratory behavior and increased expression of nociceptive genes in sensory ganglia. At later stages, cells of pancreatic origin could be found in the celiac and sensory ganglia along with metastases to the spinal cord. These results demonstrate that the nervous system participates in all stages of PDAC, including those that precede the appearance of cancer.


Subject(s)
Carcinoma, Pancreatic Ductal/secondary , Pancreas/innervation , Pancreatic Neoplasms/pathology , Spinal Cord Neoplasms/secondary , Animals , Autonomic Fibers, Postganglionic/pathology , Carcinoma, Pancreatic Ductal/metabolism , Cell Line, Tumor , Ganglia, Sympathetic/pathology , Humans , Hypertrophy , Mice , Mice, Inbred C57BL , Mice, Transgenic , Nerve Growth Factors/metabolism , Neurons, Afferent/metabolism , Neurons, Afferent/pathology , Pancreas/pathology , Pancreatic Neoplasms/metabolism , Receptors, Nerve Growth Factor/metabolism , Spinal Cord Neoplasms/metabolism , Transcriptome
3.
Schizophr Res ; 115(2-3): 261-9, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19804960

ABSTRACT

BACKGROUND: Alterations in the inhibitory circuitry of the dorsolateral prefrontal cortex (DLPFC) in schizophrenia include reduced expression of the messenger RNA (mRNA) for somatostatin (SST), a neuropeptide present in a subpopulation of gamma-aminobutyric acid (GABA) neurons. Neuropeptide Y (NPY) is expressed in a subset of SST-containing interneurons and lower levels of NPY mRNA have also been reported in schizophrenia spectrum disorders. However, whether the alterations in these two transcripts identify the same, particularly vulnerable, subset of GABA neurons has not been examined. METHODS: We used in situ hybridization to quantify NPY mRNA levels in DLPFC gray and white matter from 23 pairs of subjects with schizophrenia or schizoaffective disorder and matched normal control subjects; results were compared to those from a previous study of SST mRNA expression in the same subjects. RESULTS: In contrast to SST mRNA, NPY mRNA levels were not significantly lower in the gray matter of subjects with schizophrenia or schizoaffective disorder. However, NPY, but not SST, mRNA expression was significantly lower in the superficial white matter of subjects with schizoaffective disorder. CONCLUSION: These findings suggest that the alterations in SST-containing interneurons in schizophrenia and schizoaffective disorder are selective for the subset that do not express NPY mRNA, and that lower NPY mRNA expression in the superficial white matter may distinguish subjects with schizoaffective disorder from those with schizophrenia.


Subject(s)
Gene Expression Regulation/physiology , Neuropeptide Y/genetics , Prefrontal Cortex/metabolism , Prefrontal Cortex/pathology , Psychotic Disorders/pathology , RNA, Messenger/metabolism , Adult , Aged , Analysis of Variance , Case-Control Studies , Female , Humans , Male , Middle Aged , Neuropeptide Y/metabolism , Psychotic Disorders/physiopathology , Somatostatin/genetics , Somatostatin/metabolism , Young Adult
4.
Brain Struct Funct ; 213(1-2): 119-27, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18560887

ABSTRACT

Cortico-ventral basal ganglia circuitry is associated with a variety of mental health disorders including obsessive-compulsive disorder and drug addiction, disorders that emerge during childhood through young adulthood, a period in which the cortex and striatum continue to development. Moreover, cell proliferation, which is associated with development and plasticity, also continues in the cortex and striatum through adulthood. Given the implication of cortico-basal ganglia circuitry in diseases emerging during postnatal development, we studied cell proliferation at different ages in striatal regions associated with specific frontal cortical areas. The results show cell proliferation throughout the striatum at all postnatal ages. The majority of the new cells were immunoreactive for NG2 chondroitin sulfate, a marker for specific progenitor cells, but not for NeuN, a neuronal marker. Although neurogenesis was not observed, approximately 30% of the new cells appeared to be paired with a neuron. There was a significantly higher degree of cell proliferation during the first postnatal year compared to other striatal regions. Finally, throughout the juvenile years, the ventral striatal areas receiving input from the ventral, medial prefrontal cortex and orbital prefrontal cortex have significantly more new cells compared to other striatal regions. Integrity of the ventral striatum is critical for the development of goal-directed behaviors. The high number of new cells in the ventral striatum during postnatal development may be particularly important for the refinement of the cortico-striatal network, and in the formation of neural ensembles fundamental to learning during behavioral development.


Subject(s)
Basal Ganglia/cytology , Cell Proliferation , Corpus Striatum/cytology , Neurons/metabolism , Age Factors , Animals , Antigens/metabolism , Basal Ganglia/growth & development , Basal Ganglia/metabolism , Bromodeoxyuridine/metabolism , Corpus Striatum/growth & development , Corpus Striatum/metabolism , Immunohistochemistry , Macaca fascicularis , Male , Nerve Tissue Proteins/metabolism , Neural Pathways/cytology , Neural Pathways/growth & development , Neural Pathways/metabolism , Neuroglia/cytology , Neuroglia/metabolism , Neurons/cytology , Prefrontal Cortex/cytology , Prefrontal Cortex/growth & development , Prefrontal Cortex/metabolism , Proteoglycans/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL